Processa Pharmaceuticals, Inc. · NASDAQ:PCSA
Lin Patrick bought 1,511 Processa Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 30, 2026 · Filed May 1, 2026
On Apr 30, 2026, Lin Patrick (Chief Business - Strategy Off) bought 1,511 Processa Pharmaceuticals, Inc. shares at US$2.69 for US$4,065, leaving 6,236 shares. Filed May 1, 2026 (Form 4).
- Bought
- 1,511 shares
- Price
- US$2.69
- Value
- US$4,065
- Holding after
- 6,236 shares
- Trading plan
- No
- Role
- Chief Business - Strategy Off
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | Buy | 1,511 | US$2.69 | 6,236 | Direct |
Source
Related
- Processa Pharmaceuticals, Inc.
- Lin Patrick
- Processa Pharmaceuticals, Inc. shareholders
- Form 4 · Lin Patrick · Jul 1, 2026
- Form 4 · Lin Patrick · Jun 16, 2026
- Form 4 · Lin Patrick · Jun 1, 2026
- Form 4 · Lin Patrick · May 19, 2026
- Form 4 · Lin Patrick · Apr 17, 2026
- Schedule 13G · Soleus Capital Master Fund, L.P. · Aug 18, 2026
- Form 4 · Ng George K · Aug 11, 2026
- Form 4 · Ng George K · Jul 1, 2026
- Form 4 · Guy Wendy · Jul 1, 2026
- Form 4 · Skibsted Russell · Jul 1, 2026